Zdravlje has state-of-the-art, EU-GMP approved manufacturing facilities which serve approximately 40 countries from its base in Leskovac, Serbia.  We have an uninterrupted supply track record over 70 years.  Today our major markets include the EU, UK, Australia, North America, Latin America, Asia Pacific and Africa.  We have capabilities across all major forms of oral solid (e.g. tablets, capsules) and non-sterile liquid (sprays, drops) production with a total annual capacity of approximately 1.7 billion units.  We harness advanced manufacturing processes to manufacture products in immediate release (IR) and modified release (MR) forms. Products are manufactured, packaged, stored and released according to the highest European standards.

Finished products fully tested and released in the EU.